
Featured
FDA Approves First CRISPR Gene Therapy for Alzheimer's Disease: A New Era in Neurodegenerative Treatment
The FDA has approved the first CRISPR gene therapy for Alzheimer's disease, targeting the APOE4 gene to halt cognitive decline and clear amyloid plaqu...
Read Full Story →